ANI Pharmaceuticals, Inc. (ANIP)
USD 53.88
(-3.49%)
USD 53.88
(-3.49%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 486.81 Million | 316.38 Million | 216.13 Million | 208.47 Million | 206.54 Million | 201.57 Million |
| Cost of Revenue | 181.51 Million | 138.78 Million | 100.61 Million | 87.15 Million | 63.15 Million | 73.02 Million |
| Gross Profit | 305.3 Million | 177.6 Million | 115.52 Million | 121.31 Million | 143.39 Million | 128.55 Million |
| Operating Expenses | 195.98 Million | 203.33 Million | 143.69 Million | 136.88 Million | 126.96 Million | 93.19 Million |
| Selling, General and Administrative Expenses | 161.69 Million | 124.04 Million | 84.29 Million | 64.98 Million | 55.84 Million | 44.06 Million |
| Research and Development Expenses | 34.28 Million | 22.31 Million | 11.36 Million | 16 Million | 19.8 Million | 15.38 Million |
| Other Expenses | - | 56.97 Million | 48.03 Million | 55.9 Million | 51.31 Million | -550 Thousand |
| Cost and Expenses | 439.84 Million | 342.11 Million | 244.3 Million | 224.04 Million | 190.12 Million | 166.21 Million |
| Operating Income | 46.97 Million | -25.06 Million | -32.51 Million | -16.06 Million | 16.35 Million | 35.35 Million |
| Interest Expense | 26.94 Million | 28.05 Million | 11.92 Million | 9.45 Million | 12.96 Million | 14.75 Million |
| Income Tax Expense | 1.09 Million | -14.76 Million | -13.45 Million | -3.41 Million | -2.93 Million | 4.55 Million |
| Earnings before Tax | 19.87 Million | -62.66 Million | -56.05 Million | -25.96 Million | 3.15 Million | 20.05 Million |
| Net Income | 18.77 Million | -47.89 Million | -42.6 Million | -22.54 Million | 6.09 Million | 15.49 Million |
| Earnings Per Share Basic | 0.95 | -2.95 | -3.38 | -1.88 | 0.51 | 1.33 |
| Earnings Per Share Diluted | 0.94 | -2.95 | -3.38 | -1.88 | 0.50 | 1.32 |
| Weighted Average Shares Outstanding | 18 Million | 16.26 Million | 12.59 Million | 11.96 Million | 11.84 Million | 11.67 Million |
| Weighted Average Shares Outstanding (Diluted) | 18.19 Million | 16.26 Million | 12.59 Million | 11.96 Million | 12.04 Million | 11.77 Million |
| Gross Margin | 0.63 | 0.56 | 0.53 | 0.58 | 0.69 | 0.64 |
| EBIT Margin | 0.22 | 0.10 | 0.07 | 0.14 | 0.29 | 0.34 |
| Profit Margin | 0.04 | -0.15 | -0.20 | -0.11 | 0.03 | 0.08 |
| EBITDA | 109.32 Million | 48.06 Million | -1.68 Million | 29.06 Million | 60.73 Million | 69.1 Million |
| Earnings Before Tax Margin | 0.10 | -0.08 | -0.15 | -0.08 | 0.08 | 0.18 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 138.04 Million | 137.43 Million | 131.65 Million | 486.81 Million | 131.82 Million | 116.54 Million |
| Cost of Revenue | 72.39 Million | 63.84 Million | 68.61 Million | 241.3 Million | 48.1 Million | 42.28 Million |
| Gross Profit | 65.64 Million | 73.58 Million | 63.04 Million | 245.51 Million | 83.72 Million | 74.26 Million |
| Operating Expenses | 60.11 Million | 58.53 Million | 54.32 Million | 195.98 Million | 68.33 Million | 60.82 Million |
| Selling, General and Administrative Expenses | 52.82 Million | 48.02 Million | 44.46 Million | - | 42 Million | 38.76 Million |
| Research and Development Expenses | 7.29 Million | 10.51 Million | 9.86 Million | - | 11.12 Million | 7.37 Million |
| Other Expenses | -88 Thousand | -32 Thousand | -33 Thousand | -159 Thousand | -39 Thousand | -53 Thousand |
| Cost and Expenses | 132.51 Million | 122.37 Million | 122.94 Million | 437.28 Million | 116.43 Million | 103.1 Million |
| Operating Income | 5.52 Million | 15.05 Million | 8.71 Million | 49.52 Million | 17.94 Million | 12.4 Million |
| Interest Expense | 4.65 Million | 4.6 Million | 5.58 Million | 27.52 Million | 6.39 Million | 7.1 Million |
| Income Tax Expense | - | 7.12 Million | -208 Thousand | 1.09 Million | 1.57 Million | -996 Thousand |
| Earnings before Tax | -2.28 Million | 25.33 Million | 947 Thousand | 19.87 Million | 11.51 Million | 5.24 Million |
| Net Income | -2.28 Million | 18.2 Million | 1.15 Million | 18.77 Million | 9.94 Million | 6.24 Million |
| Earnings Per Share Basic | -0.12 | 0.84 | 0.04 | - | 0.50 | 0.33 |
| Earnings Per Share Diluted | -0.12 | 0.83 | 0.04 | - | 0.50 | 0.33 |
| Weighted Average Shares Outstanding | 19.32 Million | 19.09 Million | 19 Million | 18 Million | 18.88 Million | 17.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 19.32 Million | 19.42 Million | 19.21 Million | 18.19 Million | 19.12 Million | 17.85 Million |
| Gross Margin | 0.48 | 0.54 | 0.48 | 0.50 | 0.64 | 0.64 |
| EBIT Margin | 0.15 | 0.22 | 0.18 | - | 0.23 | 0.24 |
| Profit Margin | -0.02 | 0.13 | 0.01 | 0.04 | 0.08 | 0.05 |
| EBITDA | 20.22 Million | 29.74 Million | 23.9 Million | - | 30.56 Million | 28.07 Million |
| Earnings Before Tax Margin | 0.04 | 0.11 | 0.07 | 0.10 | 0.14 | 0.11 |
NVS
AKEJF
SMREF
0IPY
CNM
3930